Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Aichinger

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Journal of Medicinal Chemistry|August 5, 2024
Discovery of a Myeloid Cell Leukemia 1 (Mcl-1) Inhibitor That Demonstrates Potent <i>In Vivo</i> Activities in Mouse Models of Hematological and Solid TumorsJames C Tarr, James M Salovich, Martin Aichinger, et al.
Nature|November 9, 2018
The metabolite BH4 controls T cell proliferation in autoimmunity and cancerShane J F Cronin, Corey Seehus, Adelheid Weidinger, et al.
Nature|August 1, 2019
Publisher Correction: The metabolite BH4 controls T cell proliferation in autoimmunity and cancerShane J F Cronin, Corey Seehus, Adelheid Weidinger, et al.
Science Translational Medicine|September 3, 2025
An allele-agnostic mutant-KRAS inhibitor suppresses tumor maintenance signals and reprograms tumor immunity in pancreatic cancerKathleen M McAndrews, Francesca Paradiso, Clint A Stalnecker, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Journal of Medicinal Chemistry|August 5, 2024
Discovery of a Myeloid Cell Leukemia 1 (Mcl-1) Inhibitor That Demonstrates Potent <i>In Vivo</i> Activities in Mouse Models of Hematological and Solid TumorsJames C Tarr, James M Salovich, Martin Aichinger, et al.
Nature|November 9, 2018
The metabolite BH4 controls T cell proliferation in autoimmunity and cancerShane J F Cronin, Corey Seehus, Adelheid Weidinger, et al.
Nature|August 1, 2019
Publisher Correction: The metabolite BH4 controls T cell proliferation in autoimmunity and cancerShane J F Cronin, Corey Seehus, Adelheid Weidinger, et al.
Science Translational Medicine|September 3, 2025
An allele-agnostic mutant-KRAS inhibitor suppresses tumor maintenance signals and reprograms tumor immunity in pancreatic cancerKathleen M McAndrews, Francesca Paradiso, Clint A Stalnecker, et al.
Pageof 3